Publications | Lund University Publications

1 – 10 of 12

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22Cancer+therapy%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2025
Mark Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy
Yadav, Amit Singh ^LU ; Aydemir, Umut ^LU ; Hellman, Karin ^LU ; Ekström, Peter ^LU ; Mousa, Abdelrazek H ^LU ; Li, Jiaxin ^LU ; Shameem, Muhammad Anwar ^LU ; Dicko, Cedric ^LU ; Bengzon, Johan ^LU and Ek, Fredrik ^LU , et al. (2025) In Nature Communications 16(1).
- Contribution to journal › Article
2024
Mark International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer - Principles of Classification and Emerging Clinical Utility
Warrick, J.I. ; Höglund, M. ^LU and Cheng, Liang (2024) In American Journal of Surgical Pathology 48(1). p.32-42
- Contribution to journal › Article
2023
Mark Targeting miRNA by CRISPR/Cas in cancer : advantages and challenges
Hussen, Bashdar Mahmud ; Rasul, Mohammed Fatih ^LU ; Abdullah, Snur Rasool ; Hidayat, Hazha Jamal ; Faraj, Goran Sedeeq Hama ; Ali, Fattma Abodi ; Salihi, Abbas ; Baniahmad, Aria ; Ghafouri-Fard, Soudeh and Rahman, Milladur ^LU , et al. (2023) In Military Medical Research 10(1).
- Contribution to journal › Scientific review
Mark Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium
Omar, M.I. ; Bjartell, A. ^LU and N’Dow, James (2023) In Nature Reviews Urology 20(8). p.494-501
- Contribution to journal › Article
2022
Mark Testicular Dysfunction Among Cancer Survivors
Elenkov, Angel ^LU and Giwercman, Aleksander ^LU (2022) In Endocrinology and Metabolism Clinics of North America 51(1). p.173-186
- Contribution to journal › Scientific review
2020
Mark ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
Persson, Camilla U. ^LU ; von Stedingk, Kristoffer ^LU ; Fredlund, Elina ^LU ; Bexell, Daniel ^LU ; Påhlman, Sven ^LU ; Wigerup, Caroline ^LU and Mohlin, Sofie ^LU (2020) In Experimental Cell Research 388(2).
- Contribution to journal › Article
2019
Mark The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
Hellsten, Rebecka ^LU ; Lilljebjörn, Lisa ; Johansson, Martin ; Leandersson, Karin ^LU and Bjartell, Anders ^LU (2019) In Prostate 79(14). p.1611-1621
- Contribution to journal › Article
2018
Mark The role of phosphatidylinositol 4-phosphate 5-kinase type І alpha (PIP5K1α) and utility of its inhibitor for targeting metastatic cancer
Sarwar, Martuza ^LU (2018) In Lund University, Faculty of Medicine Doctoral Dissertation Series 2018(145).
- Thesis › Doctoral thesis (compilation)
2016
Mark Cellular targets of HAMLET, their role in tumor cell death and therapeutic potential
Nadeem, Aftab ^LU (2016)
- Thesis › Doctoral thesis (compilation)
2013
Mark MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
Zirath, Hanna ; Frenzel, Anna ; Oliynyk, Ganna ; Segerstrom, Lova ; Westermark, Ulrica K. ; Larsson, Karin ; Thorén, Matilda ^LU ; Hultenby, Kjell ; Lehtio, Janne and Einvik, Christer , et al. (2013) In Proceedings of the National Academy of Sciences 110(25). p.10258-10263
- Contribution to journal › Article

« previous
1
2
next »

your query:: Remove keywords: Cancer therapy